TEAL GASBARRO: Open Payments
NPI 1154722213 · CATSKILL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$644 in 42 payments from 7 companies in 2025. Trend: 2023 $652 · 2024 $832 · 2025 $644
Food & beverage: $644
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $176 |
| Novo Nordisk Inc | 14 | $135 |
| AstraZeneca Pharmaceuticals LP | 7 | $115 |
| PFIZER INC. | 4 | $81 |
| Lilly USA, LLC | 4 | $69 |
| Abbott Laboratories | 2 | $40 |
| BridgeBio Pharma, Inc. | 1 | $26 |
Products named: TRELEGY ELLIPTA, MOUNJARO, PREVNAR 20, Ozempic, BREZTRI, Rybelsus, FREESTYLE LIBRE 3, SHINGRIX.
Industry payments across NY — which companies pay providers there.
